IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/f6efe2b81ce1ebfb2e66ebaa511e8ead.pdf
Abstract Title
IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY
First Name *
Jonathan
Last Name *
Barratt
Co-author 1
Jürgen Flöge jfloege@ukaachen.de University Hospital, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Division of Nephrology Aachen
Co-author 2
Vishal Duggal duggal.vishal@gene.com Genentech, Inc. Clinical Science South San Francisco
Co-author 3
Nadine Schmit nadine.schmit@roche.com F. Hoffmann-La Roche Ltd PD Clinical Science Basel
Co-author 4
Ji Cheng emmy.cheng@roche.com Hoffmann-La Roche Ltd PD Data Sciences Mississauga
Co-author 5
Jeannette Lo lo.jeannette@gene.com Genentech, Inc. Translational Medicine South San Francisco
Co-author 6
Brad Rovin Brad.Rovin@osumc.edu The Ohio State University College of Medicine Department of Internal Medicine Columbus
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos